HYTN Innovations Inc. announced that its wholly owned subsidiary, HYTN Cannabis Inc., has entered into a sales, distribution and marketing agreement with Rose LifeScience Inc. The Agreement provides a path for HYTN to sell its products, through Rose, to la Société québécoise du cannabis (the "SQDC") and supports the Company's goal of delivering its consistent, natural and delicious cannabis products featuring Elevation Technology(R) to every province and territory in Canada. HYTN notes that it has achieved vendor qualification in all Canadian markets. However, Quebec is a unique market that requires hands on experience and on the ground presence.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 CAD | 0.00% | +3.03% | +385.71% |
1st Jan change | Capi. | |
---|---|---|
+385.71% | 19.3M | |
+6.99% | 271B | |
+3.29% | 46.59B | |
+14.27% | 22.89B | |
-12.60% | 16.73B | |
+16.79% | 12.55B | |
+21.70% | 11.22B | |
+4.84% | 11.15B | |
+5.10% | 9.21B | |
+51.38% | 6.32B |
- Stock Market
- Equities
- HYTN Stock
- News HYTN Innovations Inc.
- Hytn Innovations Inc. Announces That Its Wholly Owned Subsidiary, Hytn Cannabis Inc. Enters into Sales, Distribution and Marketing Agreement with Rose Lifescience Inc